Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 114Lung Neoplasms 83Lymphoma 76Head and Neck Neoplasms 76Glioblastoma 75Squamous Cell Carcinoma of Head and Neck 71Breast Neoplasms 71Rectal Neoplasms 67Esophageal Neoplasms 63Prostatic Neoplasms 59Leukemia 57Central Nervous System Neoplasms 54Pancreatic Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Lymphoma, Non-Hodgkin 43Lymphoma, Large B-Cell, Diffuse 43Hodgkin Disease 42Lymphoma, Follicular 41Brain Neoplasms 40Leukemia, Lymphocytic, Chronic, B-Cell 39Esophageal Squamous Cell Carcinoma 39Colorectal Neoplasms 38Burkitt Lymphoma 37Gliosarcoma 36Lymphoma, Large-Cell, Immunoblastic 33Uterine Cervical Neoplasms 31Neoplasms 31Adenocarcinoma Of Esophagus 31Lymphoma, Mantle-Cell 30Lymphoma, B-Cell, Marginal Zone 29

Interventions

Doxorubicin 8Vincristine 7Etoposide 7Cyclophosphamide 7Rituximab 5Prednisone 5Filgrastim 5Zidovudine 3Bleomycin 3Vinblastine 2Thalidomide 2Paclitaxel 2Mitoxantrone 2Interferon-alpha 2Interferon alpha-2 2Dacarbazine 2Cytarabine 2Cisplatin 2ziconotide 1vesnarinone 1tin etiopurpurin 1nirogacestat 1liposomal doxorubicin 1interferon gamma-1b 1fludarabine phosphate 1fludarabine 1efavirenz 1dehydroftorafur 1Whole-Body Irradiation 1Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × HIV Infections × Radiotherapy × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡